Latest Breaking News On - Vincerx pharma daily - Page 2 : vimarsana.com

Cantor Fitzgerald Reaffirms Overweight Rating for Vincerx Pharma (NASDAQ:VINC)

Cantor Fitzgerald Reaffirms Overweight Rating for Vincerx Pharma (NASDAQ:VINC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesVincerx pharmaTejara capital ltdCantor fitzgeraldVincerx pharma company profileMillennium managementAffinity asset advisorsVincerx pharma incRenaissance technologiesGet free reportCapital ltdAsset advisorsExoduspoint capital managementPoint capital managementVincerx pharma daily

FY2024 EPS Estimates for Vincerx Pharma, Inc Raised by Analyst (NASDAQ:VINC)

Vincerx Pharma, Inc. (NASDAQ:VINC – Free Report) – Analysts at Cantor Fitzgerald boosted their FY2024 EPS estimates for shares of Vincerx Pharma in a research report issued to clients and investors on Monday, April 1st. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will post earnings of ($0.63) per share for the year, […]

United statesCantor fitzgeraldVincerx pharmaSusquehanna international groupGoldman sachs group incVincerx pharma incVincerx pharma company profileFree reportInternational groupSachs groupMontreal canExoduspoint capital managementGet free reportVincerx pharma daily

Vincerx Pharma s (VINC) Overweight Rating Reaffirmed at Cantor Fitzgerald

Vincerx Pharma s (VINC) Overweight Rating Reaffirmed at Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesVincerx pharmaCitadel advisorsSage rhino capitalAffinity asset advisorsVanguard group incCantor fitzgeraldVincerx pharma incGet free reportRhino capitalAsset advisorsSprings capital managementVincerx pharma daily

Vincerx Pharma (NASDAQ:VINC) Receives Overweight Rating from Cantor Fitzgerald

Vincerx Pharma (NASDAQ:VINC) Receives Overweight Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesVincerx pharmaVincerx pharma company profileWalleye capitalCantor fitzgeraldVincerx pharma incGoldman sachs group incSusquehanna international groupGet free reportInternational groupSachs groupPoint capital managementVincerx pharma daily

Vincerx Pharma (VINC) to Release Quarterly Earnings on Tuesday

Vincerx Pharma (VINC) to Release Quarterly Earnings on Tuesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesVincerx pharmaTejara capital ltdCitadel advisorsVincerx pharma incMillennium managementGet free reportPoint capital managementMontreal canCapital ltdVincerx pharma daily